Bicara Therapeutics Inc. Common Stock

NASDAQ:BCAX

Biotechnology

Healthcare
$9.12 +0.00%

+$0.00 today

Market cap
$605.45M
Beta
-0.53
P/E (TTM)
-8.8
EPS (TTM)
-$2.59
52W Low $8.48High $24.25

Volume 0.84M

Average 0.54M

Balance Sheet

Inspect the capital base behind the business.

Assets

$430.99M

FY 2025 · Annual

-24.3% YoY

Liabilities

$29.54M

FY 2025 · Annual

-61.8% YoY

Equity

$401.45M

FY 2025 · Annual

-18.4% YoY

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents4.16M230.44M489.71M96.69M
Short-term Investments000318.12M
Net Receivables0000
Inventory0000
Other Current Assets68K100K12.82M7.25M
Total Current Assets4.98M231.07M502.53M422.05M
Property, Plant & Equipment (Net)636K815K845K2.03M
Goodwill0000
Intangible Assets0000
Long-term Investments0000
Tax Assets0059.2M0
Other Non-current Assets1.08M2.09M6.62M6.91M
Total Non-current Assets1.72M2.91M66.66M8.94M
Total Assets6.7M233.98M569.2M430.99M
Account Payables5.14M3.19M4.51M5.52M
Short-term Debt00607K0
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities009.79M22.32M
Total Current Liabilities23.9M15.09M17.99M28.95M
Long-term Debt0000
Deferred Tax Liabilities0059.2M0
Deferred Revenue (Non-current)0000
Other Non-current Liabilities85K17K00
Total Non-current Liabilities85K389K59.33M593K
Total Liabilities23.98M15.47M77.32M29.54M
Common Stock2K2K7K7K
Retained Earnings(101.04M)(153.02M)(221.02M)(358.97M)
Accumulated OCI000243K
Other Stockholders Equity0000
Minority Interest0000
Total Equity(17.28M)218.51M491.88M401.45M
Total Debt0657K738K1.71M
Net Debt(4.16M)(229.78M)(488.97M)(94.98M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$323.5M
Short-term Investments$216.3M
Other Current$5.2M
Total Current Assets$544.9M
PP&E (Net)$1.8M
Other Non-current$6.9M
Total Non-current Assets$8.7M
Total Assets$553.6M

Analysis

Selected assets total $553.6M for Latest. The largest visible component is Cash & Equivalents at $323.5M, about 58.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-8S-8 filingNov 10, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13G/ASC 13G/A filingOct 7, 2026
4Statement of changes in beneficial ownershipSep 10, 2026

How much cash does BCAX have?

Bicara Therapeutics Inc. Common Stock (BCAX) reported $96.69M in cash and equivalents in fiscal 2025.

How much debt does BCAX carry?

Bicara Therapeutics Inc. Common Stock (BCAX) reported $1.71M of total debt, with net debt of -$94.97M.